— Know what they know.
Not Investment Advice

FBIOX

Fidelity Select Biotechnology Portfolio
1W: +0.3% 1M: -6.2% 3M: -4.8% YTD: -2.6% 1Y: +29.2% 3Y: +62.1% 5Y: +21.6%
$25.71
-0.06 (-0.23%)
 
Weekly Expected Move ±3.5%
$23 $23 $24 $25 $26
ETF NASDAQ · AUM $5.4B

Portfolio Health Summary

IS Overall Score
59.9
Altman Z-Score
12.88
Safe
Weight Coverage
89%
of portfolio analyzed
Holdings Matched
145
with fundamental data

InsiderStreet Scorecard

59.9
Profitability
58.4
Balance Sheet
50.3
Earnings Quality
55.6
Growth
68.1
Value
37.0
Momentum
74.9
Safety
75.2

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
12.88
Safe Zone (>2.99)
Piotroski F-Score
4.9 / 9
Moderate
Beneish M-Score
3.08
Possible Manipulator
Credit Score
Earnings Quality
55.6 / 100

Portfolio Valuation

P/E
53.89x
P/B
39.46x
P/S
6.08x
EV/EBITDA
15.74x
EV/Revenue
7.22x
P/FCF
21.62x
P/OCF
20.42x
PEG
-4.38x
Earnings Yield
1.86%
FCF Yield
4.63%
OCF Yield
4.90%
Median P/E
-7.24x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +50.1%
Net Income +39.6%
EPS +44.5%
FCF +27.4%
EBITDA +44.2%
Op. Income

Compound Growth Rates

Rev CAGR 3Y +50.7%
Rev CAGR 5Y +34.7%
EPS CAGR 3Y -12.3%
EPS CAGR 5Y +4.2%
FCF CAGR 3Y +6.2%
FCF CAGR 5Y +3.6%
EBITDA CAGR 3Y +8.6%
EBITDA CAGR 5Y +14.2%
Payout Ratio
104.24%
Buyback Yield
0.35%
Dividend Yield
0.90%
Total Shareholder Return
-2.95%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$25.71
Median 1Y
$27.33
5th Pctile
$17.32
95th Pctile
$43.08
Ann. Volatility
26.8%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 53.89
Portfolio P/B 39.46
Portfolio P/S 6.08
EV/EBITDA 15.74
EV/Revenue 7.22
P/FCF 21.62
P/OCF 20.42
PEG -4.38
Earnings Yield 1.86%
FCF Yield 4.63%
OCF Yield 4.90%
Median P/E -7.24
Profitability & Returns (9)
MetricValue
Gross Margin 83.23%
Operating Margin 26.59%
Net Margin 10.16%
FCF Margin 27.32%
ROE 75.47%
ROA 4.57%
ROIC 17.69%
ROCE
Asset Turnover
Leverage & Solvency (6)
MetricValue
Debt/Equity 7.34
Debt/Assets 0.51
Net Debt/EBITDA 2.06
Interest Coverage 3.83
Current Ratio 0.90
Quick Ratio 0.75
Efficiency (4)
MetricValue
Asset Turnover
Inventory Turnover
Receivables Turnover
Payables Turnover
Growth — YoY (6)
MetricValue
Revenue Growth 50.06%
Net Income Growth 39.58%
EPS Growth 44.49%
FCF Growth 27.39%
EBITDA Growth 44.19%
Op. Income Growth
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 50.72%
Revenue CAGR 5Y 34.70%
Revenue CAGR 10Y
EPS CAGR 3Y -12.29%
EPS CAGR 5Y 4.19%
EPS CAGR 10Y
FCF CAGR 3Y 6.25%
FCF CAGR 5Y 3.56%
FCF CAGR 10Y
EBITDA CAGR 3Y 8.64%
EBITDA CAGR 5Y 14.22%
EBITDA CAGR 10Y
Net Income CAGR 3Y -12.38%
Net Income CAGR 5Y 3.59%
Op. Income CAGR 3Y
Op. Income CAGR 5Y
Quality Scores (13)
MetricValue
IS Overall 59.9
IS Profitability 58.4
IS Balance Sheet 50.3
IS Earnings Quality 55.6
IS Growth 68.1
IS Value 37.0
IS Momentum 74.9
IS Safety 75.2
IS Quality 63.2
Altman Z-Score 12.88
Piotroski F-Score 4.87
Beneish M-Score 3.08
Credit Score
Dividends & Payout (4)
MetricValue
Dividend Yield 0.90%
Payout Ratio 104.24%
Buyback Yield 0.35%
Total Shareholder Return -2.95%
Growth Stability (4)
MetricValue
Revenue Stability 0.736
Earnings Stability 0.427
Earnings Persistence 0.663
Margin Stability 0.766
Medians (3)
MetricValue
Median P/E -7.24
Median P/B 4.00
Median Dividend Yield
Coverage Meta (3)
MetricValue
Weight Coverage % 89.38%
Holdings Matched 145
Total Holdings 147

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms